For over six decades, M J Shah Group has established a cornerstone of trust and legacy, meticulously crafted by the unwavering dedication of its customers and stakeholders. Our journey commenced in 1959, embarking on a pioneering course within the pharmaceutical industry through Biochem Pharmaceutical Industries.

Biochem quickly etched its name in the annals of medical history, extending its reach across eight nations, including Thailand, Malaysia, Kenya, and Sri Lanka. Its contributions to the field were nothing short of groundbreaking: the first company to introduce the formidable antibiotic Ampicillin to India, playing a pivotal role in safeguarding our nation's well-being during the 1965 conflict. Furthermore, Biochem ushered in a paradigm shift in cancer treatment by securing an exclusive license from Japan and introducing the first-ever anti-cancer Mitomycin-C injections. Their relentless pursuit of innovation continued with the 1985 launch of Amikacin Sulphate injections, effectively combating formidable bacterial infections.

In 2017 the group strategically began its real estate business as a developer. Known for ethical and clean business practices, it was a natural progression for the group to enter the realty industry with the advent of RERA; and to turn the rich experience it has gathered through its investments venture, into a separate realty company.

The group has 5 residential real estate projects under development in Bandra (W), Upper Chembur, Lower Parel & Navi Mumbai totalling to approx. 50+ lacs sqft, providing housing to 2000+ families by 2026.

The principle of "creating value" is not just a tagline; it permeates every facet of our organization. From ideation to execution, we meticulously assess and implement strategies that resonate with our customers' evolving needs, desires, and aspirations. This unwavering commitment is the cornerstone of our success and the foundation upon which we build a brighter future for all stakeholders.